Michael Casamento
Executive Vice President and Chief Financial Officer at Amcor
Thanks, Ron, and hi, everyone. Beginning with the Flexibles segment on slide seven. Year-to-date reported sales grew 2%, which included a recovery of higher raw material costs of approximately $490 million, representing 6% sales growth. Excluding the raw material impact of negative currency movements, sales grew 3%, driven by favorable price/mix benefits across all Flexibles business units, partly offset by 2% lower volumes.. Our strategic focus on higher-value priority categories has continued to drive year-to-date sales growth, particularly strong volume growth in the health care and pet care categories has helped limit the impact of lower volumes in other categories such as protein and premium coffee.
The business has continued to show solid operating cost performance and recovery of inflation, resulting in a 5% year-to-date increase in adjusted EBIT on a comparable constant currency basis. Margins remained strong at 12.4% despite the 80 basis point dilution related to increased sales dollars from passing through higher raw material costs. In terms of the third quarter, a few call outs worth touching on. Net sales on a comparable constant currency basis were 2% higher, reflecting positive price/mix benefits. Volumes were down 3% in the quarter as market conditions led to a combination of lower consumer demand and customer destocking to varying degrees across all Flexibles businesses.
This compares to a 1% reduction in volumes in the first half of the year, with the greatest sequential declines in Europe and North America, where compared with the same quarter last year, volumes were down mid-single digits and low single digits, respectively. In both regions, the overall trends towards lower volumes and month-to-month variability is consistent with retail scanner data with categories such as premium coffee and protein being incrementally impacted by customer destocking. This also contributed to unfavorable mix in the quarter, along with expected slowing of growth rates in health care as we cycled strong growth in the prior year. Adjusted EBIT for the quarter was broadly in line with the prior year on a comparable constant currency basis, reflecting unfavorable volume and mix trends and ongoing cost inflation.
This was offset by continued pricing actions and benefits from cost productivity and cost reduction initiatives, which increased as we progressed through the quarter. Turning to Rigid Packaging on slide eight. On a year-to-date basis, net sales were 8% higher than the same period last year, including approximately $260 million or 11% of sales related to the pass-through of higher raw material costs. Organic sales declined by 2%, reflecting 3% lower volumes, partly offset by 1% price/mix benefits. In North America, overall beverage volumes for the first nine months were down 5%, hot fill volumes were up 2% and are significantly up over the past two years, with growth in key categories, including isotonics, juices and ready-to-drink tea, offset by lower cold fill container volumes, which reflects a combination of lower consumer demand and customer destocking.
Specialty container volumes were comparable with last year, and Latin America volumes were down 2% with challenging economic conditions leading to lower consumption across most of the region. Year-to-date adjusted EBIT was in line with last year as strong earnings growth in the first half was offset by a more challenging March quarter. Adjusted EBIT margin of 7.2% includes an adverse impact of approximately 80 basis points from the increased sales dollar related to passing through higher raw material costs. Looking at the March quarter, Comparable constant currency net sales were down 4% with continued soft consumer demand and customer destocking driving volumes lower in both North America and Latin America. Adjusted EBIT for the quarter was down $7 million on a constant currency basis, reflecting unfavorable volume and mix trends and ongoing cost inflation.
This was partly offset by benefits from cost reduction initiatives. And as Ron mentioned earlier, volatility has been particularly notable in North America beverage business, with order patterns changing on a week-to-week basis, significantly impacting our ability to flex costs quickly enough in response. Combined with mid-single-digit volume declines and unfavorable customer product mix trends, this has had a meaningful impact on operating leverage for our beverage business than we have seen in other businesses. As market-driven consumer demand remains soft and customers continue to reduce inventories, the business took a range of actions to lower costs, including reducing headcount. Across the network this year, the business has also taken temporary plant shutdowns to better align production with lower demand where possible and to prioritize our inventory reduction efforts.
Looking ahead, the June quarter is typically the seasonally strongest quarter for North America beverage business. This year, based on continued challenging market dynamics, we expect volume weakness with increased volatility mix challenges and ongoing inflation to persist through the U.S. summer and we anticipate the need to continue reducing inventories through the June quarter. As a result, relative to what we have seen in the March quarter, we expect this combination of factors to have a larger unfavorable impact on June quarter earnings compared to the same quarter last year. Moving to cash on the balance sheet on slide nine. Our financial profile remains strong with leverage at 3.1 times on a trailing 12-month EBITDA basis, broadly in line with last year and where we would expect it to be at this time of year.
Year-to-date cash flow remains below last year, mostly related to lower accounts payable balances as we moderate our purchasing activities, partly to reduce inventories, but also to reflect the soft demand environment. This is a timing impact, which will abate in the coming quarters. We are already making good progress on inventories with balances coming down over the last several months, and we expect a further reduction in the June quarter. Our cash flow is typically weighted to the fourth quarter, and we expect adjusted free cash flow in Q4 to be broadly in line with last year. This brings me to our outlook on slide 10. Given our expectation that current market conditions will persist in the near term, leading to a mid-single-digit overall volume decline in the fourth quarter, we are updating our guidance range for adjusted EPS to $0.72 to $0.74 per share assuming current foreign exchange rates prevail through the balance of the year.
We also expect full year adjusted free cash flow in the range of $800 million to $900 million, which includes our updated expectations on timing for working capital improvements. The slide lays out the elements making up our guidance. We expect a benefit of approximately 2% from share repurchases and earnings from the underlying business to be in line with last year, notwithstanding the significant market challenges we faced and will continue to face through the balance of fiscal '23. As Ron mentioned, we have already passed through more than $1 billion in price related to raw materials and general inflation and delivered $140 million of cost reductions year to date and we expect to deliver an additional $50 million to $60 million in cost savings across the business in the fourth quarter.
Throughout the year, we've also highlighted the significant nonoperating headwinds we faced from higher interest expense and the divestiture of our three plants in Russia, which will be absent or significantly reduced in the second half of fiscal '24. But combined with the benefits from the proactive actions we are taking in response to current market conditions, we are confident that earnings growth will build as we progress through the 2024 fiscal year.
With that, I'll hand back to Ron.